ES2178203T3 - Metodos y reactivos para modular la apoptosis. - Google Patents

Metodos y reactivos para modular la apoptosis.

Info

Publication number
ES2178203T3
ES2178203T3 ES98917503T ES98917503T ES2178203T3 ES 2178203 T3 ES2178203 T3 ES 2178203T3 ES 98917503 T ES98917503 T ES 98917503T ES 98917503 T ES98917503 T ES 98917503T ES 2178203 T3 ES2178203 T3 ES 2178203T3
Authority
ES
Spain
Prior art keywords
reagents
methods
modulate apoptosis
apoptosis
bap31
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98917503T
Other languages
English (en)
Inventor
Gordon C Shore
W H Florence Ng
Mai Nguyen
Philip E Branton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Application granted granted Critical
Publication of ES2178203T3 publication Critical patent/ES2178203T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA INVENCION PROPORCIONA UNA NUEVA PROTEINA DE LA APOPTOSIS: P28 BAP31. SE PROPORCIONAN TAMBIEN FRAGMENTOS POLIPEPTIDICOS DE DICHA PROTEINA, MOLECULAS DEL ACIDO NUCLEICO ANTISENTIDO DE LA P28 BAP31, ANTICUERPOS DIRIGIDOS CONTRA LA MISMA, Y PROCEDIMIENTOS PARA MODULAR LA APOPTOSIS Y PARA DETECTAR COMPUESTOS QUE LA MODULAN.
ES98917503T 1997-03-03 1998-03-02 Metodos y reactivos para modular la apoptosis. Expired - Lifetime ES2178203T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002198988A CA2198988A1 (en) 1997-03-03 1997-03-03 P28 bap31 a bcl-2 associated protein and use thereof for the modulation of apoptosis

Publications (1)

Publication Number Publication Date
ES2178203T3 true ES2178203T3 (es) 2002-12-16

Family

ID=4160084

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98917503T Expired - Lifetime ES2178203T3 (es) 1997-03-03 1998-03-02 Metodos y reactivos para modular la apoptosis.

Country Status (9)

Country Link
US (2) US6558950B1 (es)
EP (1) EP0900275B1 (es)
JP (1) JP2000511781A (es)
AT (1) ATE219515T1 (es)
AU (1) AU749896B2 (es)
CA (1) CA2198988A1 (es)
DE (1) DE69806107T2 (es)
ES (1) ES2178203T3 (es)
WO (1) WO1998039434A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059924A1 (en) * 1999-04-06 2000-10-12 President And Fellows Of Harvard College Methods and reagents for modulating caspase-mediated apoptosis
US7309693B2 (en) 2000-05-26 2007-12-18 Kensuke Egashira Preventives and remedies for pulmonary hypertension
US20090233848A1 (en) * 2004-03-09 2009-09-17 Chandra Bartholomeusz Pea15 as a Tumor Suppressor Gene
WO2008097854A2 (en) * 2007-02-02 2008-08-14 Loma Linda University Method and substances for treating hpv infection
CN101659703B (zh) * 2009-10-09 2012-12-05 天津医科大学附属肿瘤医院 抗人bap31蛋白的单克隆抗体及其制备方法和应用
JP6050289B2 (ja) * 2013-07-11 2016-12-21 Ｊｃｒファーマ株式会社 組換え蛋白質高発現細胞株の選択法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions

Also Published As

Publication number Publication date
DE69806107T2 (de) 2002-11-21
AU7071698A (en) 1998-09-22
EP0900275A1 (en) 1999-03-10
US6607880B1 (en) 2003-08-19
JP2000511781A (ja) 2000-09-12
ATE219515T1 (de) 2002-07-15
AU749896B2 (en) 2002-07-04
CA2198988A1 (en) 1998-09-03
US6558950B1 (en) 2003-05-06
EP0900275B1 (en) 2002-06-19
DE69806107D1 (de) 2002-07-25
WO1998039434A1 (en) 1998-09-11

Similar Documents

Publication Publication Date Title
ES2177939T3 (es) Construccion de proteina fluorescente en tandem.
ES2145451T3 (es) Secuencia de dna y proteina de cancer de mamas codificada especifica para mamas.
DE59913840D1 (de) Effektoren von Dipeptidylpeptidase IV
NO20004526D0 (no) Modulatorer for proteintyrosinfosfataser
ES2142569T3 (es) Procedimientos y compuestos para la deteccion magneto-relaxometrica de analitos y su utilizacion.
EA200000251A1 (ru) Производные резорцинола
BR9612258B1 (pt) inibidores de enzima conversora de interleucina-1beta, bem como composição farmacêutica.
EE9900481A (et) Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
CU22997A3 (es) Proteína híbrida para la inhibición de la desgranulación de los mastocitos y su utilización
AR021139A1 (es) Acidos nucleicos y polipeptidos de activadores de la transcripcion y metodos de uso de los mismos
PT1017692E (pt) 4-heteroaril-tetrahidroquinolinas e sua aplicacao como inibidores da proteina de transferencia de ester de colesterol (ctep)
ATE421584T1 (de) Cpg rezeptor (cpg-r) und darauf bezogene methoden
PT1303632E (pt) Oligossacarideos de galactomanano e processo para a sua preparacao bem como sua utilizacao
ATE335852T1 (de) Happier mapping
CY1109207T1 (el) Διαδικασια εχινοκανδινης
DE59912185D1 (de) Verwendung von hsp70 protein
DE60139544D1 (de) Veränderte, fluoreszierende proteine
PT981525E (pt) Novos intermediarios e processo para a sua preparacao
ES2178203T3 (es) Metodos y reactivos para modular la apoptosis.
EP1012603A4 (en) FUNCTIONAL FRAGMENTS OF THE HIV-1 VPR PROTEIN AND A METHOD FOR ITS USE
AU2001263269A1 (en) Long wavelength engineered fluorescent proteins
NL1013029A1 (nl) Vezeloptische lichtbron van hoog vermogen en met brede band.
DE69634077D1 (de) Haemophilus adhäsionsproteinen
HN1998000091A (es) Inhibidores de la farnesil transferasa tratamiento del cancer.
SE9803962L (sv) Nukleinsyra som kodar för natriumtunnel i nervvävnad